Lidocaine Patch Active Pharmaceutical Ingredient from Japan
Micronized lidocaine base specifically processed for transdermal patch matrix (particle size D90<10μm). Classified HTS 2924.29.57.00 as pure aromatic amide API before patch assembly. Meets skin permeation pharmacopeial requirements.
Duty Rate — Japan → United States
27.5%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include laser diffraction PSD report confirming D90<10μm for patch matrix compatibility
• Document polymorphic form (Form I preferred) affecting skin permeation rates
• Avoid milling post-import; particle size growth during storage affects patch performance